CL2011001992A1 - Proceso para producir 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina que comprende la etapa de precipitar el solvato isopropanol bromhidrato del compuesto a partir de un solvente con mas de 65% (v/v) de isopropanol; proceso de purificacion; y el intermediario solvato isopropanol bromhidrato del compuesto. - Google Patents

Proceso para producir 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina que comprende la etapa de precipitar el solvato isopropanol bromhidrato del compuesto a partir de un solvente con mas de 65% (v/v) de isopropanol; proceso de purificacion; y el intermediario solvato isopropanol bromhidrato del compuesto.

Info

Publication number
CL2011001992A1
CL2011001992A1 CL2011001992A CL2011001992A CL2011001992A1 CL 2011001992 A1 CL2011001992 A1 CL 2011001992A1 CL 2011001992 A CL2011001992 A CL 2011001992A CL 2011001992 A CL2011001992 A CL 2011001992A CL 2011001992 A1 CL2011001992 A1 CL 2011001992A1
Authority
CL
Chile
Prior art keywords
isopropanol
compound
hydrobromide
solvate
piperazine
Prior art date
Application number
CL2011001992A
Other languages
English (en)
Inventor
De Diego Heide Lopez
Henrik Vigan Nicolajsen
Michael Harold Rock
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of CL2011001992A1 publication Critical patent/CL2011001992A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Procedimiento para producir 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina que comprende obtener una solución disolviendo la sal 1-[2-(2,4-dimetil-fenilsufanil)-fenil]-piperazina-hbr en un solvente que comprende más del 65% (v/v) de isopropanolol; compuesto que se obtiene; y solución líquida que lo comprende.
CL2011001992A 2009-02-17 2011-08-16 Proceso para producir 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina que comprende la etapa de precipitar el solvato isopropanol bromhidrato del compuesto a partir de un solvente con mas de 65% (v/v) de isopropanol; proceso de purificacion; y el intermediario solvato isopropanol bromhidrato del compuesto. CL2011001992A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200900223 2009-02-17

Publications (1)

Publication Number Publication Date
CL2011001992A1 true CL2011001992A1 (es) 2012-04-09

Family

ID=42101395

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011001992A CL2011001992A1 (es) 2009-02-17 2011-08-16 Proceso para producir 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina que comprende la etapa de precipitar el solvato isopropanol bromhidrato del compuesto a partir de un solvente con mas de 65% (v/v) de isopropanol; proceso de purificacion; y el intermediario solvato isopropanol bromhidrato del compuesto.

Country Status (27)

Country Link
US (1) US8598348B2 (es)
EP (1) EP2398785B1 (es)
JP (1) JP5738774B2 (es)
KR (1) KR101639833B1 (es)
CN (1) CN102317272B (es)
AR (1) AR075436A1 (es)
AU (1) AU2010214956B2 (es)
BR (1) BRPI1006975B1 (es)
CA (1) CA2751498C (es)
CL (1) CL2011001992A1 (es)
CO (1) CO6400224A2 (es)
DK (1) DK2398785T3 (es)
EA (1) EA020473B1 (es)
ES (1) ES2441079T3 (es)
HR (1) HRP20131236T1 (es)
IL (1) IL214178A (es)
MX (1) MX2011008661A (es)
NZ (1) NZ594658A (es)
PL (1) PL2398785T3 (es)
PT (1) PT2398785E (es)
RS (1) RS53074B (es)
SG (1) SG173735A1 (es)
SI (1) SI2398785T1 (es)
SM (1) SMT201400010B (es)
TW (1) TW201033181A (es)
WO (1) WO2010094285A1 (es)
ZA (1) ZA201105992B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS58683B1 (sr) * 2012-01-03 2019-06-28 H Lundbeck As Postupak za proizvodnju 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina
WO2014044721A1 (en) 2012-09-19 2014-03-27 Sandoz Ag Novel crystalline form of vortioxetine hydrobromide
PL2931276T3 (pl) 2012-12-13 2018-06-29 H. Lundbeck A/S Kompozycje zawierające wortioksetynę i donepezil
RU2652265C2 (ru) * 2013-02-22 2018-04-27 Х. Лундбекк А/С Способ получения вортиоксетина
US20160200698A1 (en) 2013-09-12 2016-07-14 Hangzhou Pushai Pharmaceutical Technology Co., Ltd Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usage
US10414741B2 (en) 2013-09-30 2019-09-17 Cadila Healthcare Limited Amorphous vortioxetine and salts thereof
EP2878596A1 (en) * 2013-11-29 2015-06-03 LEK Pharmaceuticals d.d. Synthesis of vortioxetine via (2-(piperazine-1-yl)phenyl)lithium intermediates
CN103788020B (zh) * 2014-01-22 2015-11-04 苏州明锐医药科技有限公司 沃替西汀的制备方法
CN103788019B (zh) * 2014-01-22 2015-10-07 苏州明锐医药科技有限公司 沃替西汀的制备方法
CN106103418A (zh) 2014-01-31 2016-11-09 埃吉斯药物私人有限公司 沃替西汀盐的制备方法
CN104059030B (zh) * 2014-05-30 2016-05-04 镇江圣安医药有限公司 [(苯硫烷基)-苯基]哌嗪的衍生物及其药物组合物和用途
CN105218482B (zh) * 2014-06-24 2018-04-06 杭州和泽医药科技有限公司 沃替西汀氢溴酸盐β晶型的制备方法
US9687484B2 (en) 2014-07-18 2017-06-27 Dipharma Francis S.R.L. Crystalline forms of an antidepressant compound
WO2016079751A2 (en) 2014-11-17 2016-05-26 Megafine Pharma (P) Ltd. A process for preparation of vortioxetine and polymorphs thereof
CN105669594A (zh) * 2014-11-19 2016-06-15 康普药业股份有限公司 抗抑郁症药1-[2-(2,4-二甲基苯基硫基)苯基]哌嗪的制备方法
CN105801517A (zh) * 2014-12-30 2016-07-27 上海奥博生物医药技术有限公司 一种沃替西汀氢溴酸盐新晶型及其制备方法
WO2016125190A2 (en) 2015-02-04 2016-08-11 Mylan Laboratories Limited Novel crystalline forms of vortioxetine, premixes, and processes for the preparation thereof
US20180072690A1 (en) 2015-03-26 2018-03-15 Cipla Limited Methods for Making Serotonin Reuptake Inhibitors
CN105439980B (zh) * 2015-05-08 2017-10-24 北京北陆药业股份有限公司 一种氢溴酸沃替西汀一仲丁醇合物及其制备方法
CN105367515B (zh) * 2015-05-08 2017-10-27 北京北陆药业股份有限公司 一种氢溴酸沃替西汀α晶型的制备方法
CN106316985B (zh) * 2015-06-18 2021-11-09 郑州深蓝海生物医药科技有限公司 一种β型高效氢溴酸沃替西汀转晶方法
WO2017125504A1 (en) * 2016-01-20 2017-07-27 Amneal Pharmaceuticals Company Gmbh Polymorphic forms of vortioxetine hydrobromide tert-butanolate
WO2018002115A1 (en) 2016-07-01 2018-01-04 H. Lundbeck A/S Vortioxetine dosing regimes for fast onset of antidepressant effect
US10519121B2 (en) 2016-12-30 2019-12-31 Apicore Us Llc Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
US11124491B2 (en) * 2017-04-25 2021-09-21 H. Lundbeck A/S Process for the manufacture of vortioxetine HBr alpha-form
CN108017595A (zh) * 2017-12-20 2018-05-11 安徽源久源科技有限公司 一种1-[2-(2,5-二甲基苯硫基)苯基]哌嗪的制备方法
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
CN112125868B (zh) * 2020-09-25 2021-08-03 中山万远新药研发有限公司 一种氢溴酸伏硫西汀晶型及其制备方法、组合物与用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB852974A (en) 1958-04-17 1960-11-02 Parke Davis & Co Ethers and means for producing the same
FR2186237B1 (es) 1972-05-03 1975-10-31 Synthelabo
US5576460A (en) 1994-07-27 1996-11-19 Massachusetts Institute Of Technology Preparation of arylamines
UA81749C2 (uk) 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
CA2656057C (en) * 2006-06-16 2012-10-02 H. Lundbeck A/S Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
PL2044043T5 (pl) * 2006-06-16 2022-05-02 H. Lundbeck A/S Bromowodorek 1-[2-(2,4-dimetylofenylosulfanylo)fenylo]piperazyny jako związek o połączonym działaniu wychwytu zwrotnego serotoniny i działaniu na 5-ht3 i 5-ht1a do leczenia upośledzenia funckji poznawczych
TW200848411A (en) * 2007-03-20 2008-12-16 Lundbeck & Co As H Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine

Also Published As

Publication number Publication date
PT2398785E (pt) 2013-12-26
US20120004409A1 (en) 2012-01-05
SMT201400010B (it) 2014-03-07
SG173735A1 (en) 2011-09-29
HK1165955A1 (en) 2012-10-12
NZ594658A (en) 2013-02-22
CN102317272B (zh) 2014-11-12
AU2010214956B2 (en) 2012-08-23
ZA201105992B (en) 2012-10-31
CA2751498A1 (en) 2010-08-26
RS53074B (sr) 2014-04-30
EP2398785B1 (en) 2013-11-27
BRPI1006975B1 (pt) 2022-11-22
EA020473B1 (ru) 2014-11-28
AR075436A1 (es) 2011-03-30
EA201171065A1 (ru) 2012-02-28
US8598348B2 (en) 2013-12-03
CO6400224A2 (es) 2012-03-15
CN102317272A (zh) 2012-01-11
PL2398785T3 (pl) 2014-07-31
IL214178A0 (en) 2011-08-31
DK2398785T3 (da) 2013-12-16
KR20110126625A (ko) 2011-11-23
KR101639833B1 (ko) 2016-07-14
JP2012517961A (ja) 2012-08-09
JP5738774B2 (ja) 2015-06-24
ES2441079T3 (es) 2014-01-31
AU2010214956A1 (en) 2011-09-22
SI2398785T1 (sl) 2014-01-31
CA2751498C (en) 2017-09-12
MX2011008661A (es) 2011-09-06
IL214178A (en) 2014-09-30
TW201033181A (en) 2010-09-16
BRPI1006975A2 (pt) 2020-08-18
EP2398785A1 (en) 2011-12-28
HRP20131236T1 (hr) 2014-02-14
WO2010094285A1 (en) 2010-08-26

Similar Documents

Publication Publication Date Title
CL2011001992A1 (es) Proceso para producir 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina que comprende la etapa de precipitar el solvato isopropanol bromhidrato del compuesto a partir de un solvente con mas de 65% (v/v) de isopropanol; proceso de purificacion; y el intermediario solvato isopropanol bromhidrato del compuesto.
CR20160032A (es) Compuestos de pirimidinodiona contra estados cardíacos
CL2011002090A1 (es) Complejo de haluro de agomelatina, que corresponde a un derivado de naftaleno; procedimiento de preparacion del mismo.
CO6531458A2 (es) Nuevos compuestos de espiropiperidina
CR20120296A (es) Nuevos compuestos de espiropiperidina
CO6491074A2 (es) Recuperacion de alcoholes superiores a partir de soluciones acuosas diluidas
AR108319A1 (es) Un proceso y un aparato para producir una solución polimérica acuosa
IT201700071890A1 (it) Metodo per la produzione di soluzioni acquose disinfettanti e detergenti tramite una cella elettrolitica coassiale a diaframma
CL2017000944A1 (es) Compuesto heterocíclico
CU20120137A7 (es) Hidrato del hidrocloruro de agomelatina y preparación de éste
EA201101097A1 (ru) Новые микробиоциды
CL2008002748A1 (es) Proceso para recuperar un polimero desde una solucion por inyeccion de vapor; y proceso para reciclar un polimero.
CL2008001513A1 (es) Uso de hidrofobinas como auxiliares en la cristalizacion de un solido; proceso para la produccion de un solido por cristalizacion a partir de una fase acuosa y separando el solido formado desder la fase acuosa.
CL2008002777A1 (es) Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario.
AR087345A1 (es) Metodos para la preparacion de compuestos de tiofeno
PE20121473A1 (es) Uso de 4-[etil(dimetil)amonio]butanoato en el tratamiento de enfermedades cardiovasculares
AR068801A1 (es) Proceso para la produccion de un compuesto de toluidina como ingrediente activo de plaguicidas
CL2017001868A1 (es) Proceso de obtención de nanopartículas de cobre a partir de un hongo seleccionado entre hypocrea lixii y trichoderma koningiopsis y uso de los hongos seleccionados entre hypocrea lixii y trichoderma koningiopsis en biorremediación de aguas residuales y producción de nanopartículas de cobre (divisional de sol. n°1474-14)
CO6331375A2 (es) Un proceso para la recuperacion de sulfuro metalico a partir de una solucion que contiene el ion del metal
MA35147B1 (fr) Nouveau procede de synthese du (2e)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
UA112596C2 (uk) Концентрування розчину сечовини в способі синтезу сечовини
AR071804A1 (es) Cristales de sucralosa enjuagados con regulador (buffer)
AR077523A1 (es) Procedimiento para aislar tigeciclina y tigeciclina elaborada a partir del procedimiento
AR094240A1 (es) Proceso para producir cristal de compuesto de pirazol
GT201700068A (es) Sistema de aplicación antimicrobiana con reciclaje y captura